CytoSorbents Receives Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program Medical Device Investing
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND Pharmaceutical Investing
Cellular Biomedicine Group Announces Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy Genetics Investing
Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate Life Science Investing
Novartis LEE011 (ribociclib) Plus Letrozole Analyses Show Superior PFS in First-Line HR+/HER2- Advanced Breast Cancer Life Science Investing
Myriad Genetics' EndoPredict® Test Significantly Outperforms the First-Generation Test in Predicting the Risk of Node-Negative and Node-Positive Breast Cancer Recurrence Medical Device Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
